Research summary
Clinical, laboratory and radiologic features were analyzed for 138 suspected SARS cases admitted to Prince of Wales Hospital isolation wards between March 11 and 25, 2003, with univariate and multivariate analysis of intensive-care need and death as clinical endpoints [1]. A randomized trial of 651 chronic hepatitis B patients with histologically confirmed cirrhosis or advanced fibrosis (436 to lamivudine 100 mg daily, 215 to placebo, 2:1 allocation, up to five years) examined time to disease progression defined by hepatic decompensation, hepatocellular carcinoma, spontaneous bacterial peritonitis, variceal bleeding or liver-related death [2]. A global review of colorectal cancer screening programs catalogued geographical variation in CRC incidence, economic resources, healthcare infrastructure and screening strategies [3]. Plasma Th1, inflammatory and Th2 cytokines and chemokines were profiled in 20 SARS patients, showing sustained elevation of IFN-gamma, IL-1, IL-6 and IL-12 for at least two weeks after onset without significant TNF-alpha, IL-10, IL-2 or IL-4 elevation [4]. Transient elastography liver-stiffness measurement was evaluated in 246 NAFLD patients with satisfactory liver biopsy specimens from two ethnic groups, with AUROC analysis for F3+ and F4 fibrosis and analysis of discordance factors between elastography and histology [5]. Metagenome-wide association on fecal samples from 74 Chinese CRC patients and 54 controls (with Danish, French and Austrian validation cohorts) confirmed Fusobacterium nucleatum and Peptostreptococcus stomatis CRC associations, identified new biomarkers, and evaluated targeted qPCR diagnostic performance in 47 patients and 109 controls [6].
Recent publications
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesDOI
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisDOI
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populationsDOI
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong KongDOI
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseDOI
- Colorectal cancerDOI
- Colorectal cancer screening: a global overview of existing programmesDOI
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeDOI
- Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver DiseaseDOI
- Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancerDOI
The lab page does not clearly state student acceptance status. Email the professor directly to confirm.
How to apply
Email Joseph J.�Y. Sung 6-12 months before your application deadline. Read several recent papers and reference specific work in your message. Use our how to email a Japanese professor guide for the proven email structure.
For applications via MEXT scholarship: see our MEXT 2027 complete guide and university-specific University Recommendation track.
External profiles
- ORCID: https://orcid.org/0000-0003-3125-5199
- OpenAlex: openalex.org
Profile compiled from public sources (Researchmap, OpenAlex, Kumamoto University faculty directory). Last refreshed 2026-05. Report incorrect information.